NASDAQ · Biotechnology

KPRX (KPRX) Stock

$2.64 +3.13% NASDAQ: KPRX Healthcare

Valuation

MetricValue
Price$2.64
Market Cap$11.70M
P/E Ratio-1.00
P/B Ratio0.73
P/S Ratio0.00
EPS (TTM)$-2.64
52-Week High$3.29
52-Week Low$1.76
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-68.75%
ROA-45.83%
ROCE-56.25%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.03
Current Ratio5.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$16.0M$0
Operating Profit$-14.0M$-12.0M$-13.0M$5.0M$-9.0M
Net Profit$-14.0M$-14.0M$-13.0M$4.0M$-11.0M
EPS$-68.00$-18.55$-24.25$0.87$-2.64
Op Margin———28.2%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$20.0M$19.0M$14.0M$36.0M$24.0M
Total Liabilities$6.0M$7.0M$8.0M$11.0M$8.0M
Cash$8.0M$6.0M$2.0M$4.0M$9.0M
Borrowings$0$0$0$0$0

Latest News

SS Innovations International (SSII) Appoints Sarah Romano as Chief Financial Officer NewMediaWire · Jul 15, 2026 SS Innovations names Sarah Romano as CFO MedTech Dive · Jul 15, 2026 Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium TMX Newsfile · Jul 2, 2026 Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model TMX Newsfile · Jun 18, 2026 Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update TMX Newsfile · May 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-10.0M$-10.0M$9.0M$-10.0M
Investing Cash Flow$0$0$0$-23.0M$14.0M
Financing Cash Flow$0$3.0M$-1.0M$0$0
Net Cash Flow$7.0M$-2.0M$-4.0M$1.0M$5.0M
Free Cash Flow$-11.0M$-10.0M$-10.0M$9.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-88.69%
Quick Ratio6.68
Interest Coverage—
Return 1Y-17.33%
Return 3Y-56.61%
Return 5Y-99.79%

Ownership

Insiders Held3.08%
Institutions Held28.92%
Institutions Float Held29.83%
Institutional HolderSharesReport Date
Adar1 Capital Management, LLC 167,9412026-03-31
Citadel Advisors Llc49,5332026-03-31
Geode Capital Management, LLC47,8502026-03-31
Vanguard Capital Management LLC19,8612026-03-31
Xtx Topco Ltd14,7192026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACXP $1.40 -1.40% -0.36 $2.22M 0.00%
ADIL $3.33 +1.22% -1.14 $3.20M 0.00%
APRE $0.62 -1.16% -0.47 $4.06M 0.00%
APVO $4.21 -4.10% -0.06 $9.21M 0.00%
BCDABioCardia, Inc. $0.84 -1.11% -0.83 $4.88M 0.00%

About KPRX

KPRX is led by CEO Brian Strem, employs 12 people, headquartered in US, publicly traded since 2015.

KPRX stock trades at $2.64 with a market capitalization of $11.70M. The stock is valued at a price-to-earnings (P/E) ratio of -1.00, price-to-book of 0.73, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.76 and $3.29, and currently trades 19.8% below its 52-week high.

On profitability, KPRX generates a return on equity (ROE) of -68.75%, return on capital employed of -56.25%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides